Literature DB >> 11966763

Expression of eotaxin, an eosinophil-selective chemokine, parallels eosinophil accumulation in the vesiculobullous stage of incontinentia pigmenti.

S Jean-Baptiste1, E A O'Toole, M Chen, J Guitart, A Paller, L S Chan.   

Abstract

Incontinentia pigmenti (IP) is an X-linked dominant genodermatosis primarily affecting female children. The initial vesiculobullous stage of IP is characterized clinically by inflammatory papules, blisters, and pustules, and histopathologically by acanthosis, keratinocyte necrosis, epidermal spongiosis and massive epidermal eosinophil infiltration. The cause of this multisystem disease is attributed to the mutations of an X-linked regulatory gene, termed nuclear factor-kappaB essential modulator (NEMO). The exact mechanism of epidermal eosinophil accumulation has not yet been determined. We explored the possible role of an eosinophil-selective, nuclear factor-kappaB-activated chemokine, eotaxin, in the accumulation of eosinophils in the initial stage of the disease. Monoclonal antibody (6H9) specific for human eotaxin strongly labelled the suprabasal epidermis of IP skin, paralleling the upper epidermal accumulation of eosinophils, but did not label the epidermis of normal skin or lesional skin from patients with other inflammatory skin diseases not characterized by prominent eosinophil accumulation, namely dermatitis herpetiformis and selected cases of atopic dermatitis lacking significant numbers of eosinophils. In addition, endothelial cells in lesional skin of IP also exhibited strong expression of eotaxin, which correlated with perivascular and intravascular eosinophil infiltration. We also examined the in vitro effects on epidermally derived eotaxin of several cytokines that were nuclear factor-kappaB-activated and/or known to induce eotaxin expression. In normal human keratinocytes, proinflammatory cytokines either independently (IL-1alpha) or synergistically (tumour necrosis factor-alpha (TNF-alpha)/ interferon-gamma (IFN-gamma) and TNF-alpha/IL-4) up-regulated eotaxin expression. These studies suggest that release of cytokines during the initial inflammatory stage of IP induces epidermal expression of eotaxin, which may play a role in the epidermal accumulation of eosinophils.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11966763      PMCID: PMC1906303          DOI: 10.1046/j.1365-2249.2002.01755.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

Review 1.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

Authors:  P J Barnes; M Karin
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

Review 2.  Incontinentia pigmenti (Bloch-Sulzberger syndrome).

Authors:  S J Landy; D Donnai
Journal:  J Med Genet       Date:  1993-01       Impact factor: 6.318

3.  Human dermal fibroblasts express eotaxin: molecular cloning, mRNA expression, and identification of eotaxin sequence variants.

Authors:  J Bartels; C Schlüter; E Richter; N Noso; R Kulke; E Christophers; J M Schröder
Journal:  Biochem Biophys Res Commun       Date:  1996-08-23       Impact factor: 3.575

4.  Chemokine expression in human oral keratinocyte cell lines and keratinized mucosa.

Authors:  M Bickel; S M Nöthen; K Freiburghaus; D Shire
Journal:  J Dent Res       Date:  1996-11       Impact factor: 6.116

5.  Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids.

Authors:  C M Lilly; H Nakamura; H Kesselman; C Nagler-Anderson; K Asano; E A Garcia-Zepeda; M E Rothenberg; J M Drazen; A D Luster
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

Review 6.  The molecular genetics of incontinentia pigmenti.

Authors:  J L Gorski; E N Burright
Journal:  Semin Dermatol       Date:  1993-09

7.  Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response.

Authors:  J A Ganzalo; G Q Jia; V Aguirre; D Friend; A J Coyle; N A Jenkins; G S Lin; H Katz; A Lichtman; N Copeland; M Kopf; J C Gutierrez-Ramos
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

8.  Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia.

Authors:  E A Garcia-Zepeda; M E Rothenberg; R T Ownbey; J Celestin; P Leder; A D Luster
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

9.  Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.

Authors:  P D Ponath; S Qin; D J Ringler; I Clark-Lewis; J Wang; N Kassam; H Smith; X Shi; J A Gonzalo; W Newman; J C Gutierrez-Ramos; C R Mackay
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

10.  Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia.

Authors:  M E Rothenberg; J A MacLean; E Pearlman; A D Luster; P Leder
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

View more
  11 in total

Review 1.  Genodermatoses caused by genetic mosaicism.

Authors:  M Vreeburg; M A M van Steensel
Journal:  Eur J Pediatr       Date:  2012-11-01       Impact factor: 3.183

2.  Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells.

Authors:  S Kagami; H Saeki; M Komine; T Kakinuma; Y Tsunemi; K Nakamura; K Sasaki; A Asahina; K Tamaki
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

3.  Eosinophil infiltration in three patients with generalized atrophic benign epidermolysis bullosa from a Japanese family: molecular genetic and immunohistochemical studies.

Authors:  Masayo Nomura; Yoh-Ichiro Hamasaki; Ichiro Katayama; Kuniko Abe; Norio Niikawa; Koh-Ichiro Yoshiura
Journal:  J Hum Genet       Date:  2005-09-20       Impact factor: 3.172

4.  Cerebral Arteriopathy in a Newborn With Incontinentia Pigmenti.

Authors:  Sarah B Mulkey; Raghu H Ramakrishnaiah; Tonya M Balmakund
Journal:  Pediatr Neurol       Date:  2015-09-21       Impact factor: 3.372

Review 5.  Systematic review of central nervous system anomalies in incontinentia pigmenti.

Authors:  Snežana Minić; Dušan Trpinac; Miljana Obradović
Journal:  Orphanet J Rare Dis       Date:  2013-02-13       Impact factor: 4.123

6.  Incontinentia Pigmenti: A Case Report of a Complex Systemic Disease.

Authors:  Serena Gianfaldoni; Georgi Tchernev; Uwe Wollina; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2017-07-23

7.  Regulation of eotaxin expression in skin allergic diseases.

Authors:  Cheng Peng; Hualin Zhang; Jishun Yang; Jianguo Xu; Shikui Guan; Jianjun Xia; Quangang Zhu; Benming You; Yu Zhu; Jinhong Hu; Jiyong Liu
Journal:  Postepy Dermatol Alergol       Date:  2022-07-14       Impact factor: 1.664

8.  VCAM-1 blockade delays disease onset, reduces disease severity and inflammatory cells in an atopic dermatitis model.

Authors:  Lin Chen; Shao-xia Lin; Sanober Amin; Lut Overbergh; Giacomo Maggiolino; Lawrence S Chan
Journal:  Immunol Cell Biol       Date:  2010-01-12       Impact factor: 5.126

Review 9.  Eosinophils in skin diseases.

Authors:  Susanne Radonjic-Hoesli; Marie-Charlotte Brüggen; Laurence Feldmeyer; Hans-Uwe Simon; Dagmar Simon
Journal:  Semin Immunopathol       Date:  2021-06-07       Impact factor: 9.623

Review 10.  The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease.

Authors:  Kyle T Amber; Manuel Valdebran; Khalaf Kridin; Sergei A Grando
Journal:  Front Med (Lausanne)       Date:  2018-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.